1-1 of 1
Authors: Masahiro Yamazaki
Sort by
Journal Article
Sunitinib versus sorafenib for patients with advanced renal cell carcinoma with renal impairment before the immune-oncology therapy era
Get access
Tatsuya Takayama and others
Japanese Journal of Clinical Oncology, Volume 49, Issue 12, December 2019, Pages 1164–1171, https://doi.org/10.1093/jjco/hyz127
Published: 28 October 2019
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals